Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Division of T Cell Metabolism

Dr. Guoliang Cui

B16 mouse melanoma tumor-infiltrating lymphocytes or TILs (left) are exhausted and express higher levels of inhibitory receptors (such as PD-1 and Lag-3) than splenic T cells (right). Our research goal is to understand how metabolism regulates anti-tumor T cell effector function and survival.

Cancers affect hundreds of millions of people worldwide. Immune cells, such as T cells, play a very important role in protection against cancer development. However, tumor-infiltrating T cells are frequently immunosuppressed or “exhausted”, which is characterized by expression of immune checkpoint molecules (such as PD-1, TIGIT, LAG-3, etc) and reduction of anti-tumor effector cytokines (such as IFNg, TNFa, etc). Immune checkpoint blockade has achieved huge clinical success in several types of cancers, but only a subset population of cancer patients benefit from it. This suggests that we may be still at the early stage in understanding the immunosuppressive nature of tumor microenvironment. Thus, one of the most important questions in this field is to identify the factors causing T cell exhaustion in the tumor. Our previous findings suggest that metabolites, such as lipids, regulate T cell survival and effector function. Based upon the previous work, our T Cell Metabolism group will use mouse melanoma models to identify the metabolic checkpoints regulating anti-tumor T cell bioenergetics, survival and effector functions.

The long-term research goal of our T Cell Metabolism group is to translate our findings made using the mouse models into clinical benefits. Particularly, we are interested in addressing the following questions: 1) which lipid metabolites regulate human anti-tumor T cell effector function and survival? 2) what is the mechanism underlying lipids-induced T cell immunosuppression and 3) how to enhance human anti-tumor T cell function by regulating the lipid metabolic pathways? These future studies may lead to novel immunotherapies by targeting T cell-intrinsic lipid metabolism.


Dr. Guoliang Cui
T Cell Metabolism (D192)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg
Tel: +49 6221 42 1370

Selected Publications

  • Weisshaar, N., Wu, J., Ming, Y., Madi, A., Hotz-Wagenblatt, A., Ma, S., Mieg, A., Hering, M., Zettl, F., Mohr, K., Schlimbach, T., Ten Bosch, N., Hertel, F., Müller, L., Byren, H., Wang, M., Borgers, H., Munz, M., Schmitt, L., van der Hoeven, F., Kloz, U., Carretero, R., Schleußner, N., Jackstadt, R.F., Hofmann, I., and Cui, G. (2022). Rgs16 Promotes Anti-tumor CD8+ T Cell Exhaustion. Science Immunology 7, eabh1873.
  • Xu, S., Chaudhary, O., Rodríguez-Morales, P., Sun, X., Zappasodi, R., Xu, Z., Pinto, A.F.M., Williams, A., Chen, D., Low, J.S., Farsakoglu, Y., Tang, W., Wang, H., Varanasi, S.K., McDonald, B., Tripple, V., Downes, M., Evans, R.M., Abumrad, N.A., Merghoub, T., Wolchok, J.D., Shokhirev, M.N., Ho, P.-C., Witztum, J.L., Emu, B., Cui, G.#, and Kaech, S.M#. (2021). Oxidized Lipids and CD36-Mediated Lipid Peroxidation in CD8 T Cells Suppress Anti-Tumor Immune Responses. Immunity 54, 1561 – 1577. (#co-corresponding authors)
  • Wu, J., Weisshaar, N., Hotz-Wagenblatt, A., Madi, A., Ma, S., Mieg, A., Hering, M., Mohr, K., Schlimbach, T., Borgers, H., and Cui, G. (2020). Skeletal Muscle Antagonizes Antiviral CD8+ T Cell Exhaustion. Science Advances 6:eaba3458.
  • Wu, J.*, Ma, S.*, Sandhoff, R.*, Ming, Y., Hotz-Wagenblatt, A., Timmerman, V., Bonello-Palot, N., Schlotter-Weigel, B., Auer-Grumbach, M., Seeman, P., Löscher, W.N., Reindl, M., Weiss, F., Mah, E., Weisshaar, N., Madi, A., Mohr, K., Schlimbach, T., Velasco Cárdenas, R.M.H., Koeppel, J., Grünschläger, F., Müller, L., Baumeister, M., Brügger, B., Schmitt, M., Wabnitz, G., Samstag, Y., and Cui, G. (2019). Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity 50, 1218 – 1231. (*co-first authors)
to top
powered by webEdition CMS